Scale and regulatory moat in niche Xanthine; CDMO pipeline promising but unproven long-term.

FY27 base-case growth 15-18%

CDMO project pipeline quality — The CDMO pipeline has matured significantly, with commercial projects more than doubling and development projects initially rising then stabilizing, indicating a healthy funnel conversion. Customer growth has stabilised after a strong expansion.